EP 2109454 A1 20091021 - GLP-1 PHARMACEUTICAL COMPOSITIONS
Title (en)
GLP-1 PHARMACEUTICAL COMPOSITIONS
Title (de)
PHARMAZEUTISCHE GLP-1-ZUSAMMENSETZUNGEN
Title (fr)
COMPOSITIONS PHARMACEUTIQUES À BASE DE GLP-1
Publication
Application
Priority
- US 2007026490 W 20071231
- US 64774606 A 20061229
- US 90058607 A 20070912
Abstract (en)
[origin: WO2008082656A1] The present invention is directed to peptide analogues of glucagon-like peptide-1, the pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat mammals and to pharmaceutical compositions useful therefore comprising said analogues.
IPC 8 full level
A61K 31/70 (2006.01); A61K 38/26 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01)
CPC (source: EP KR)
A61K 9/0019 (2013.01 - EP); A61K 31/70 (2013.01 - EP); A61K 33/30 (2013.01 - KR); A61K 33/34 (2013.01 - KR); A61K 38/26 (2013.01 - EP KR); A61K 47/02 (2013.01 - EP); A61K 47/12 (2013.01 - EP); A61P 3/10 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/28 (2017.12 - EP)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2008082656 A1 20080710; AU 2007340369 A1 20080710; AU 2007340369 B2 20111222; AU 2007340369 C1 20130502; CN 101668535 A 20100310; CN 101668535 B 20170728; EP 2109454 A1 20091021; EP 2109454 A4 20130605; JP 2010523473 A 20100715; KR 101247665 B1 20130402; KR 20090096739 A 20090914
DOCDB simple family (application)
US 2007026490 W 20071231; AU 2007340369 A 20071231; CN 200780051882 A 20071231; EP 07868132 A 20071231; JP 2009544117 A 20071231; KR 20097015759 A 20071231